1-26554682-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000374168.7(RPS6KA1):c.700G>A(p.Val234Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000374 in 1,613,240 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000374168.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KA1 | NM_002953.4 | c.700G>A | p.Val234Ile | missense_variant | 9/22 | ENST00000374168.7 | NP_002944.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KA1 | ENST00000374168.7 | c.700G>A | p.Val234Ile | missense_variant | 9/22 | 1 | NM_002953.4 | ENSP00000363283 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000418 AC: 105AN: 251134Hom.: 0 AF XY: 0.000435 AC XY: 59AN XY: 135706
GnomAD4 exome AF: 0.000384 AC: 561AN: 1460940Hom.: 1 Cov.: 31 AF XY: 0.000424 AC XY: 308AN XY: 726588
GnomAD4 genome AF: 0.000276 AC: 42AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.000309 AC XY: 23AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.727G>A (p.V243I) alteration is located in exon 8 (coding exon 8) of the RPS6KA1 gene. This alteration results from a G to A substitution at nucleotide position 727, causing the valine (V) at amino acid position 243 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at